Mitsubishi UFJ Asset Management’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-37,154
Closed -$168K 1572
2024
Q1
$168K Sell
37,154
-1,701
-4% -$8.68K ﹤0.01% 974
2023
Q4
$221K Buy
38,855
+4,641
+14% +$21.5K ﹤0.01% 997
2023
Q3
$157K Hold
34,214
﹤0.01% 1044
2023
Q2
$221K Buy
34,214
+19,083
+126% +$130K ﹤0.01% 1024
2023
Q1
$114K Buy
15,131
+2,140
+16% +$19.4K ﹤0.01% 1081
2022
Q4
$123K Sell
12,991
-8,875
-41% -$103K ﹤0.01% 1073
2022
Q3
$216K Buy
21,866
+9
+0% +$99 ﹤0.01% 1014
2022
Q2
$233K Buy
21,857
+5,849
+37% +$49.5K ﹤0.01% 1027
2022
Q1
$156K Buy
16,008
+1,854
+13% +$17.6K ﹤0.01% 1089
2021
Q4
$200K Buy
14,154
+7,096
+101% +$108K ﹤0.01% 1084
2021
Q3
$141K Hold
7,058
﹤0.01% 1092
2021
Q2
$155K Buy
+7,058
New +$195K ﹤0.01% 1104

Other funds holding ABCL